Download Citation
Article Source:
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial
Landovitz RJ,
Li S,
Grinsztejn B,
Dawood H,
Liu AY,
et al.
(2018)
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
PLOS Medicine 15(11): e1002690.
https://doi.org/10.1371/journal.pmed.1002690